Skip Nav Destination
1-4 of 4
Keywords: Hematological malignancyClose
Daisuke Minakata, Shin-ichiro Fujiwara, Jin Hayakawa, Hideki Nakasone, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-ichi Ochi, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Miyuki Sugimoto, Yuko Ishihara, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Tsukasa Ohmori, Yoshinobu Kanda
Acta Haematol (2020) 143 (3): 250–259.
Published Online: 28 August 2019
.... Objectives: To compare the clinical results of the treatment of DIC with danaparoid or SPIs. Methods: We retrospectively examined 188 patients with hematological malignancy-related DIC. Results: DIC resolution rate in the danaparoid group was higher than that in the SPIs group (61.5 vs. 42.6%; p = 0.031...
Acta Haematol (2017) 137 (4): 209–213.
Published Online: 18 May 2017
... that HBV is associated with other human cancers. However, the association between HBV and the risk of onset of hematological malignancies remains controversial. The aim of this large-scale retrospective cohort study was to evaluate the association between HBV infection and hematological malignancies...
Acta Haematol (2017) 137 (3): 132–140.
Published Online: 30 March 2017
...Qing Wei; Ting Niu; Mengyao Wang; Jinrong Yang; Pengpeng Liu; Yuyao Yi To retrospectively validate the prognostic value of the latest Chinese disseminated intravascular coagulation (DIC) scoring system (CDSS) in hematological malignancies, 260 patients with confirmed hematological malignancies...
Acta Haematol (2002) 107 (3): 133–144.
Published Online: 25 April 2002
...Pia Raanani; Isaac Ben-Bassat Interferon (IFN), a leukocyte-derived cytokine, has been used to treat several hematological malignancies. The most common adverse effects of IFN are flu-like symptoms. Autoimmune side effects are infrequent but may be hazardous and irreversible. These may occur...